Cardiovascular Disease· Topic 2.8 Endocarditis and other cardiovascular infection· 2.8.4

Nonbacterial thrombotic endocarditis

Nonbacterial thrombotic endocarditis (marantic endocarditis) is sterile platelet-fibrin vegetations on cardiac valves associated with malignancy and autoimmune disease, notably antiphospholipid syndrome and lupus (Libman-Sacks). It rarely destroys valves but embolizes readily, so treatment is anticoagulation and management of the underlying disease.

4 min read9 practice questions7 key factsSubscriber article
  • Topic review
    The full article, organized the way the exam asks it.
  • ABIM-format MCQs
    Vignettes with an explanation for every wrong answer.
  • Key facts
    The numbers and thresholds worth memorizing, up front.
  • AI tutor
    MedBrain answers the question you're stuck on.

What this article covers

  • Overview

    Definition: nonbacterial thrombotic endocarditis (NBTE, marantic endocarditis) is the formation of sterile vegetations of platelets and fibrin on cardiac valves in the absence of infection.

  • Epidemiology

    Associated with advanced malignancy (especially adenocarcinomas) and hypercoagulable states.

  • Risk factors

    Advanced or mucin-producing malignancy (pancreatic, lung, gastric, ovarian).

  • Pathophysiology

    Hypercoagulability and endothelial injury: a procoagulant, inflammatory state promotes deposition of platelet-fibrin thrombi on valve surfaces.

  • Clinical features

    Embolic events: stroke, and splenic, renal, coronary, or peripheral infarction.

  • Differential diagnosis

    Infective endocarditis: infected vegetations with positive blood cultures, fever, and valve destruction, unlike the sterile culture-negative vegetations of NBTE (Bacterial infective endocarditis).

  • Diagnosis

    Establish by valvular vegetations with persistently negative blood cultures in a patient with malignancy or autoimmune disease: the diagnostic basis is echocardiographic vegetations (often small…

  • Management

    First-line, anticoagulate to prevent further embolism (parenteral anticoagulation is generally preferred over an oral vitamin K antagonist in malignancy-associated disease), continued long term…

  • Complications

    Recurrent systemic embolism and infarction (stroke, organ, and limb).

  • Prognosis

    Largely determined by the underlying disease, often poor with advanced malignancy.

  • Prevention

    Anticoagulation to prevent recurrent embolism.

Read the whole article

Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.